CYTOF News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2025-08-29 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2025-06-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2025-05-09 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2025-04-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2025-03-10 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-12-20 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-10-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-09-24 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-09-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-05-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-04-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-04-10 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-01-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2024-01-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-12-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-12-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-12-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-11-22 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-11-21 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-10-31 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-10-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-09-12 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-08-21 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K/A | Altamira Therapeutics Ltd. filed Form 6-K/A. |
| 2023-07-28 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-07-26 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-07-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-07-05 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-06-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-06-27 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-06-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-05-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-05-26 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-05-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-05-02 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-04-18 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-04-13 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-04-03 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-03-09 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-02-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-01-27 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2023-01-24 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-12-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-12-05 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-11-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-11-09 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-10-24 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-10-24 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-09-29 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-09-12 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-08-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-08-26 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-06-27 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-06-13 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-06-07 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-05-19 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-05-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-04-18 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-03-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2022-02-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-12-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-09-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-07-23 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-07-21 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-06-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-06-03 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-05-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-04-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-04-13 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-03-31 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-03-12 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2021-01-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-12-10 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-12-03 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-12-02 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-10-09 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-09-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-09-17 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K/A | Altamira Therapeutics Ltd. filed Form 6-K/A. |
| 2020-09-11 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-09-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-07-02 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-06-05 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-04-23 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-04-23 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-04-21 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-04-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2020-01-09 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-10-23 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-09-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-08-15 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-05-16 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-05-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-04-30 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-04-05 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-04-04 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-03-14 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-03-14 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-03-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-02-08 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-01-29 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |
| 2019-01-28 | Foreign issuer report | SEC filing | Altamira Therapeutics Ltd. filed Form 6-K | Altamira Therapeutics Ltd. filed Form 6-K. |